Feminizing Treatment in Transgender Women and Non-binary Persons
ConditionTransgenderism
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorOdense University Hospital
About this trial
Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.
Eligibility criteria
Qualifiers
assigned male at birth and eligeble for gender affirming feminizing treatment
Disqualifiers
None
Trial design
Treatments tested in this trial
- standard treatment
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov